Rate and Predictors of Permanent Pacemaker Implantation after 
Transcatheter Aortic Valve Implantation: Current Status

Transcather aortic valve implantation (TAVI) has become a safe and indispensable treat-ment option for patients with severe symptomatic aortic stenosis who are at high surgical risk. Re-cently, outcomes after TAVI have improved significantly and TAVI has emerged as a qualified alter-native to surgical aortic valve replacement in the treatment of intermediate risk patients and greater adoption of this procedure is to be expected in a wider patients population, including younger patients and low surgical risk patients. However since the aortic valve has close spatial proximity to the con-duction system, conduction anomalies are frequently observed in TAVI. In this article, we aim to re-view the key aspects of pathophysiology, current incidence, predictors and clinical association of conduction anomalies following TAVI.